Every one of those 1 sits in a single category, telehealth. Of the tracked stories, 1 of 1 also mention FDA, the most common co-covered peer. Each carries 2 original sources on average. We currently track 1 Healthcare story that mention Louisiana, all published on July 23, 2026.
Figures are computed live from our source-verified story record
— see our methodology for how impact and
sentiment are derived.
What the coverage shows about Louisiana
Every one of those 1 sits in a single category, telehealth. Of the tracked stories, 1 of 1 also mention FDA, the most common co-covered peer. Each carries 2 original sources on average. We currently track 1 Healthcare story that mention Louisiana, all published on July 23, 2026.
Stories tracked
1
Sources per story
2
Computed from the 1 stories linked to this entity, with beat comparisons drawn from all 7 Healthcare stories published in the same date window. Shares are omitted below five stories and comparisons below a twenty-story baseline.
Coverage cohort
Appears alongside
Other entities that clear the same relevance threshold in stories also covering Louisiana. Shared-story counts are live from our verified record — not editorial picks.
Clinicians and public health advocates are sounding the alarm over a potential ban on mail-order mifepristone, which now accounts for 30% of U.S. abortions. Over 400 state lawmakers cite rural hospital closures and transportation barriers as evidence that ending telehealth abortion would create a healthcare crisis for millions.